Joanne L. Blum

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1999 · 791 citations

Medicine, Oncology, Pharmacology +16

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

Noah D. Kauff, Susan M. Domchek, Tara M. Friebel et al. · Journal of Clinical Oncology · 2008 · 590 citations · Full text

Medicine, Gynecology, Surgery +13

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Antonis C. Antoniou, Xianshu Wang, Zachary S. Fredericksen et al. · Nature Genetics · 2010 · 342 citations · Full text

Medicine, Genetics, Oncology +17

Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.

Gail E. Tomlinson, Thomas T. Chen, Victor Stastny et al. · PubMed · 1998 · 291 citations

Life Sciences, Genetics, Oncology +17

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Antonis C. Antoniou, Amanda B. Spurdle, Olga M. Sinilnikova et al. · The American Journal of Human Genetics · 2008 · 284 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14